Research graph
References from Teaching cancer patients undergoing chemotherapy in the National Health Service to use daily self-moxibustion to reduce chemotherapy-induced pancytopenia: a feasibility study. Local targets link to admitted publications; unresolved targets remain external evidence.
Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: a review
10.1016/j.ctrv.2022.102427 · 2022 · External reference
Febrile neutropenia: an ounce of prevention or a pound of cure
10.1200/jop.18.00750 · 2019 · External reference
Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently emerging clinical data
10.1016/j.critrevonc.2017.11.005 · 2017 · External reference
10.1093/oncolo/oyac074
10.1093/oncolo/oyac074 · External reference
The impact of myelosuppression on quality of life of patients treated with chemotherapy
10.2217/fon-2023-0513 · 2024 · External reference
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices
10.1200/jco.2003.05.002 · 2003 · External reference
Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management
10.1002/cncr.11882 · 2004 · External reference
Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment
10.1007/s00508-023-02300-6 · 2024 · External reference
Management of febrile neutropaenia: ESMO clinical practice guidelines
10.1093/annonc/mdw325 · 2016 · External reference
10.1016/j.ejca.2010.10.013
10.1016/j.ejca.2010.10.013 · External reference
Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update
10.1200/jco.2015.62.3488 · 2015 · External reference
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: a systematic review
10.1016/j.critrevonc.2020.103193 · 2021 · External reference
Indications for and complications of transfusion and the management of gynecologic malignancies
10.1016/j.ygyno.2017.05.010 · 2017 · External reference
Does severe anemia caused by dose-dense paclitaxel-carboplatin combination therapy have an effect on the survival of patients with epithelial ovarian cancer? Retrospective analysis of the Japanese gynecologic oncology group 3016 trial
10.1097/igc.0b013e318229266a · 2011 · External reference
10.1016/j.clinthera.2009.11.020
10.1016/j.clinthera.2009.11.020 · External reference
Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer
10.1002/14651858.cd010559.pub2 · 2018 · External reference
10.1177/15347354231198089
10.1177/15347354231198089 · External reference
10.1016/j.wjam.2025.12.001
10.1016/j.wjam.2025.12.001 · External reference
10.1177/15347354241233226
10.1177/15347354241233226 · External reference
Efficacy and safety of moxibustion on cancer-related fatigue: a systematic review and meta-analysis of randomized controlled trials
10.1007/s00520-023-07977-z · 2023 · External reference
Moxibustion for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis
10.1155/2017/9854893 · 2017 · External reference
Moxibustion for alleviating chemotherapy-induced gastrointestinal adverse effects: a systematic review of randomized controlled trials
10.1016/j.ctcp.2021.101527 · 2022 · External reference
Moxibustion as an adjuvant therapy for cancer pain: a systematic review and meta-analysis
10.2147/jpr.s396696 · 2023 · External reference
10.1007/978-94-007-4833-0_12
10.1007/978-94-007-4833-0_12 · External reference
Comparative efficacy of moxibustion in chemotherapy-induced leukopenia: a Bayesian network meta-analysis
10.1016/j.imr.2025.101145 · 2025 · External reference
Limiting chemotherapy side effects by using moxa
10.1016/j.eujim.2016.07.023 · 2016 · External reference
Extending the CONSORT statement to moxibustion
10.3736/jintegrmed2013009 · 2013 · External reference
Guidelines for designing and evaluating feasibility pilot studies
10.1097/mlr.0000000000001664 · 2022 · External reference
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
10.1177/0962280215588241 · 2016 · External reference
Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: a systematic review and meta-analysis
10.1002/onco.13822 · 2021 · External reference
The calculation of received dose intensity
10.1200/jco.1990.8.12.1935 · 1990 · External reference
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin’s lymphoma: a nationwide study
10.1200/jco.2004.03.213 · 2004 · External reference
10.1177/15347354231168368
10.1177/15347354231168368 · External reference
The functional assessment of cancer therapy scale: development and validation of the general measure
10.1200/jco.1993.11.3.570 · 1993 · External reference
Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the functional assessment of cancer therapy-neutropenia (FACT-N)
10.1007/s00520-007-0270-7 · 2008 · External reference
Development and testing of a short form of the patient activation measure
10.1111/j.1475-6773.2005.00438.x · 2005 · External reference
Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis
10.1007/s00520-022-07447-y · 2022 · External reference
The daily use of moxibustion to treat chemotherapy-induced bone marrow depression: a practical evaluation based on 20 years of clinical experience
2009 · External reference
The patient activation measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation
10.1186/s12955-024-02255-w · 2024 · External reference
The importance of dose intensity in chemotherapy of metastatic breast cancer
10.1200/jco.1984.2.11.1281 · 1984 · External reference
The influence of adjuvant chemotherapy dose intensity on five-year outcomes in resected colon cancer: a single centre retrospective analysis
10.3390/curroncol28050342 · 2021 · External reference
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations
10.1212/wnl.0000000000006083 · 2018 · External reference
